/Companies

Prevencio

Kirkland, US · Founded 2013 · Delaware corporation

Find your way into Prevencio

296 people in our graph share verified history with the Prevencio team — schools, employers, funds. One of them is your warm intro.

KEVIN GOODWINunlockedknows Rhonda Rhyne · together at FUJIFILM Sonosite, Inc. (overlapped)
knows the team · via Drexel University College of Medicine
×10knows the team · via UPMC

Prevencio develops advanced diagnostic tests for cardiac risk assessment and personalized health management. The company serves healthcare providers and patients seeking early detection and prevention of cardiovascular and metabolic disease through AI-driven biomarker testing.

Founders & leadership

Prevencio was founded in 2013 by William LaFramboise.

WLWilliam LaFramboise
William LaFramboiseCo-founderWilliam LaFramboise is co-founder of Prevencio and previously led genomics facility development and clinical genomic profiling implementation at a major healthcare system, including building a large patient biorepository and circulating tumor DNA assays for cancer monitoring.
RRRhonda Rhyne
Rhonda RhyneChief Executive Officer, President, Chief Translational Officer, and Board DirectorRhonda Rhyne has led multiple life sciences startups and served as president of a publicly traded medical device company for 12 years, where she oversaw the commercialization of more than 15 medical products and holds patents in machine learning-driven diagnostics. She is currently CEO of Prevencio, which develops AI-powered biomarker tests for cardiovascular risk assessment.
GF
Gary FrankExecutive

Board

MM
Michele McCarthyBoard director
JC
John CramerBoard director
PF
Perry FellBoard director

Reported raises · per SEC filings

Form D private placements

$9.1M disclosed across 2 rounds · 2016–2022

▶$8.4MraisedMar 2022 · 96 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Rhonda RhyneExecutive Officer, Director, Promoter
  • John Cramer IIIDirector
  • Michele McCarthyExecutive Officer, Director
Offering amount
$9.5M
Amount sold
$8.4M
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$675KraisedApr 2016 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michele McCarthyDirector
  • John CramerDirector
  • Perry FellDirector
  • Rhonda RhyneExecutive Officer, Director
  • Gary FrankExecutive Officer, Director
Offering amount
$2M
Amount sold
$675K
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Prevencio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Prevencio do?
Prevencio develops advanced diagnostic tests for cardiac risk assessment and personalized health management. The company serves healthcare providers and patients seeking early detection and prevention of cardiovascular and metabolic disease through AI-driven biomarker testing.
Who founded Prevencio?
Prevencio was founded by William LaFramboise in 2013.
How much funding has Prevencio raised?
Prevencio has disclosed $9.1M raised across 2 rounds.
Where is Prevencio headquartered?
Prevencio is headquartered in Kirkland, US.